Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	297.81	348.4	119.11	59.79	54.51
Cash & Short-Term Investments	297.81	348.4	119.11	59.79	54.51
Cash Growth	-14.52%	192.49%	99.20%	9.69%	340.65%
Accounts Receivable	314.62	337.47	204.53	154.32	153.92
Other Receivables	-	44.56	20.96	31.58	31.2
Receivables	382.99	382.02	225.48	185.9	185.11
Inventory	419.19	632.6	270.08	231.03	179.11
Other Current Assets	-	36.14	35.43	36.41	18.1
Total Current Assets	1,100	1,399	650.11	513.13	436.84
Property, Plant & Equipment	282.34	216.09	196.5	188.06	126.79
Long-Term Investments	290.25	290.25	-	-	-
Goodwill	33.95	33.95	-	-	-
Long-Term Deferred Tax Assets	2.41	1.49	0.17	0.52	0.67
Other Long-Term Assets	40.44	42.91	7.74	4.41	25.69
Total Assets	1,749	1,984	854.53	706.12	590

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	40.73	123.86	45.13	68.28	118.17
Accrued Expenses	-	15.81	5.41	4.12	12.6
Short-Term Debt	-	348.52	33.53	155.63	86.71
Current Portion of Long-Term Debt	152.16	69.98	0.85	36.16	2.26
Current Income Taxes Payable	36.4	35.72	36.71	30.91	19.39
Other Current Liabilities	57.45	42.04	52.5	72.6	75.41
Total Current Liabilities	286.74	635.91	174.13	367.69	314.54
Long-Term Debt	-	-	-	100.61	136.24
Other Long-Term Liabilities	78.07	99.97	78.06	-	-
Total Liabilities	364.81	735.88	252.2	468.3	450.78

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	155.83	155.83	139.16	50.83	10.17
Additional Paid-In Capital	-	568.23	161.28	-	7.66
Retained Earnings	-	369.33	287.88	174.85	112.96
Comprehensive Income & Other	1,055	1.25	-0.52	-0.07	0.24
Total Common Equity	1,210	1,095	587.79	225.61	131.02
Minority Interest	174.08	153.33	14.54	12.21	8.19
Shareholders' Equity	1,385	1,248	602.33	237.82	139.22
Total Liabilities & Equity	1,749	1,984	854.53	706.12	590

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	152.16	418.49	34.38	292.4	225.21
Net Cash (Debt)	145.64	-70.09	84.73	-232.6	-170.69
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	9.35	-4.82	7.95	-22.88	-16.79
Filing Date Shares Outstanding	15.55	15.58	13.92	13.92	10.17
Total Common Shares Outstanding	15.55	15.58	13.92	10.17	10.17
Working Capital	813.25	763.26	475.98	145.44	122.3
Book Value Per Share	77.82	70.25	42.24	22.19	12.89
Tangible Book Value	1,177	1,061	587.79	225.61	131.02
Tangible Book Value Per Share	75.64	68.07	42.24	22.19	12.89
Land	-	7.98	-	7.98	7.98
Buildings	-	71.07	-	51.3	12.84
Machinery	-	197.76	-	149.32	56.52
Construction In Progress	-	8.47	0.15	-	84.8

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error